Education
About Us
Working with TipRanks
Follow Us
Ultralife Corp. (ULBI)
NASDAQ:ULBI
Earnings Data
Report Date
Jul 24, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.13Last Year’s EPS
0.18Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 09, 2025
|% Change Since: 11.89%
|Next Earnings Date:Jul 24, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with robust revenue growth, driven by government-defense sales and the positive impact of the Electrochem acquisition, set against challenges such as declines in Communications Systems revenue and medical battery sales. While the company's strategic initiatives appear promising, the decrease in operating income and gross margin highlight areas of concern.Company Guidance
During the Ultralife Corporation's first quarter 2025 earnings call, the company reported consolidated revenues of $50.7 million, reflecting a 21% year-over-year increase, with a notable 53.6% growth in government-defense sales. The Battery & Energy Products segment contributed $46.3 million, up from $35 million in the prior year, excluding sales from the recent Electrochem acquisition. However, the Communications Systems segment experienced a 36.2% decline in revenues to $4.4 million. The company achieved a gross profit of $12.7 million with a gross margin of 25.1%, down 230 basis points from the previous year due to product mix. Operating income stood at $3.4 million, translating to $0.11 EPS on a GAAP basis and $0.13 on an adjusted basis. The total backlog was $95 million, representing 55% of trailing 12-month sales. Despite challenges, Ultralife remains optimistic about future growth, driven by strategic initiatives and the integration of Electrochem, with expectations to complete the ERP system transition by the end of Q2 2025.Strong Year-over-Year Revenue Growth
Ultralife Corporation reported Q1 sales of $50.7 million, an increase from $41.9 million in the first quarter of 2024, representing a year-over-year growth of approximately 21%.
Government-Defense Sales Increase
Government-defense sales increased by 53.6%, driven by heightened demand for Ultralife's products by U.S. primes.
Positive Contribution from Electrochem Acquisition
The Electrochem acquisition contributed positively to the results, with integration on track to complete in Q2.
Improved Operating Efficiency
Ultralife is executing targeted supply chain strategies and lean productivity projects to improve gross margin.
Strong Backlog
Ultralife's total backlog exiting the first quarter was $95 million, representing a healthy 55% of trailing 12-month sales.
ULBI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ULBI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 09, 2025 | $4.88 | $5.05 | +3.48% |
Apr 01, 2025 | $5.38 | $5.05 | -6.13% |
Nov 08, 2024 | $9.28 | $7.98 | -14.01% |
Jul 25, 2024 | $11.37 | $10.91 | -4.05% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ultralife Corp. (ULBI) report earnings?
Ultralife Corp. (ULBI) is schdueled to report earning on Jul 24, 2025, TBA Not Confirmed.
What is Ultralife Corp. (ULBI) earnings time?
Ultralife Corp. (ULBI) earnings time is at Jul 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ULBI EPS forecast?
ULBI EPS forecast for the fiscal quarter 2025 (Q2) is 0.13.